Zatuximab Chimeric Monoclonal Antibody
Zatuximabis a research-grade recombinant antibody targeting HER1. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
HER1, Receptor tyrosine-protein kinase erbB-1, Proto-oncogene c-ErbB-1, Epidermal growth factor receptor, EGFR, ERBB1, ERBB
UniProt
P00533
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF640R conjugate, 0.1mg/mL
P27 / KIP1 (SX53G8), CF594 conjugate, 0.1mg/mL
Cytochrome C (CYCS/1010), CF568 conjugate, 0.1mg/mL
Chromogranin A / CHGA (Neuroendocrine Marker) (rCHGA/413), CF647 conjugate, 0.1mg/mL
P27 / KIP1 (DCS-72.F6 + KIP1/769 (SX53G8) ), CF568 conjugate, 0.1mg/mL
